iodine has been researched along with Adenocarcinoma, Follicular in 48 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Adenocarcinoma, Follicular: An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Radioiodine ((131)I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease." | 8.81 | Radioiodine therapy for papillary and follicular thyroid carcinoma. ( Baudin, E; Klain, M; Leboulleux, S; Ricard, M; Schlumberger, M, 2002) |
| " Examination of a biopsy from the right ilium revealed a metastasis from a highly differentiated follicular thyroid carcinoma, which could not be demonstrated scintigraphically because of a reduced 99mTc-pertechnetate and 123I-iodine uptake, the result of the L-thyroxine administration." | 8.79 | [Iodine-induced hyperthyroidism in metastatic thyroid carcinoma]. ( Ehlenz, K; Joseph, K; Joseph, U; Leppek, R; Rothmund, M; Schmidt, JA; von Wichert, P, 1994) |
| "The incidence of hyperthyroidism among thyroid malignancy varies greatly depending on the geographical area and iodine intake." | 7.73 | The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency. ( Alagol, H; Camlibel, M; Dinc, S; Gulcelik, MA; Gulcelik, NE; Kuru, B, 2006) |
| "To evaluate and compare staging systems for differentiated thyroid carcinoma and predicted outcome in an endemic goiter region with iodine substitution and to examine the risk profile of differentiated thyroid carcinoma and compare it against nongoiter regions." | 7.72 | Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. ( Kaserer, K; Niederle, B; Passler, C; Prager, G; Scheuba, C; Zettinig, G, 2003) |
| " The aim of this study is to show differences in outcome and specific prognostic factors in an iodine-replete endemic goiter region." | 7.72 | Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. ( Kaczirek, K; Kaserer, K; Niederle, B; Passler, C; Prager, G; Scheuba, C; Zettinig, G, 2004) |
| "In 1990 rise in thyroid cancer IR was observed." | 5.31 | [Iodine deficiency and thyroid neoplasms in the Krakow region]. ( Buziak-Bereza, M; Gołkowski, F; Huszno, B; Pantofliński, J; Przybylik-Mazurek, E; Szybiński, Z; Trofimiuk, M, 2001) |
| " In iodine deficient areas, chronic stimulation by TSH causes multinodular autonomous growth and function, leading to hyperthyroidism in middle-aged and elderly subjects." | 4.84 | [Epidemiology of thyroid tumors: effect of environmental iodine intake]. ( Kasagi, K, 2007) |
| "Radioiodine ((131)I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease." | 4.81 | Radioiodine therapy for papillary and follicular thyroid carcinoma. ( Baudin, E; Klain, M; Leboulleux, S; Ricard, M; Schlumberger, M, 2002) |
| " Examination of a biopsy from the right ilium revealed a metastasis from a highly differentiated follicular thyroid carcinoma, which could not be demonstrated scintigraphically because of a reduced 99mTc-pertechnetate and 123I-iodine uptake, the result of the L-thyroxine administration." | 4.79 | [Iodine-induced hyperthyroidism in metastatic thyroid carcinoma]. ( Ehlenz, K; Joseph, K; Joseph, U; Leppek, R; Rothmund, M; Schmidt, JA; von Wichert, P, 1994) |
| "The prevalence and pathology pattern of iodine deficiency (ID) related disorders are influenced by the dietary iodine intake: low iodine leads to thyroid nodular enlargement, to an increase in the incidence of thyroid cancer, an increase in anaplastic carcinomas and to an alteration in the papillary to follicular neoplasia ratio." | 3.81 | Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa. ( Castelo Branco, M; Freitas, M; Kalk, WJ; Marques Carreira, I; Santos, JE, 2015) |
| "Follicular thyroid carcinoma (FTC) and Hurthle cell carcinoma (HCC) of the thyroid are relatively uncommon thyroid malignancies in iodine-sufficient areas." | 3.80 | Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data. ( Cho, BY; Chung, JH; Jang, HW; Jo, YS; Kim, SW; Kim, TH; Kim, TY; Kim, WB; Kim, WG; Park, DJ; Park, YJ; Shong, M; Shong, YK, 2014) |
| "The incidence of hyperthyroidism among thyroid malignancy varies greatly depending on the geographical area and iodine intake." | 3.73 | The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency. ( Alagol, H; Camlibel, M; Dinc, S; Gulcelik, MA; Gulcelik, NE; Kuru, B, 2006) |
| "To evaluate and compare staging systems for differentiated thyroid carcinoma and predicted outcome in an endemic goiter region with iodine substitution and to examine the risk profile of differentiated thyroid carcinoma and compare it against nongoiter regions." | 3.72 | Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. ( Kaserer, K; Niederle, B; Passler, C; Prager, G; Scheuba, C; Zettinig, G, 2003) |
| " The aim of this study is to show differences in outcome and specific prognostic factors in an iodine-replete endemic goiter region." | 3.72 | Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. ( Kaczirek, K; Kaserer, K; Niederle, B; Passler, C; Prager, G; Scheuba, C; Zettinig, G, 2004) |
| "The functional role of the sodium iodide symporter (NIS) in extrathyroidal tissues was investigated by examining its mRNA and protein expression, together with the evidence of radioiodine (131)I uptake in 302 patients who underwent (131)I total body scanning, following the administration of high doses of (131)I for a papillary or follicular thyroid carcinoma." | 3.72 | Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues. ( Baudin, E; Bruno, R; Filetti, S; Giannasio, P; Ronga, G; Russo, D; Schlumberger, M; Travagli, JP, 2004) |
| "These data suggest that the potential malignancy of thyroid nodules is not only correlated to the diameter but to other parameters such as the biological difference of thyroid cancer that could be hypothesized in an iodine deficiency area." | 3.71 | [Prevalence and aggressiveness of thyroid carcinoma with diameter less than one centimetre in iodine deficiency areas]. ( Agosti, B; Cappelli, C; Cerudelli, B; Cumetti, D; Morassi, ML; Pelizzari, G; Tironi, A, 2002) |
| "The incidence of differentiated thyroid cancer has been increasing in the last decades all over the world." | 2.72 | Nutritional status and follicular-derived thyroid cancer: An update. ( Adinolfi, V; Baldelli, R; Barrea, L; Barucca, V; Colao, A; Gallo, M; Giacinto, PD; Muscogiuri, G; Prinzi, N; Renzelli, V; Ruggeri, RM; Sesti, F, 2021) |
| "Radioiodine has been used as a diagnostic and therapeutic tool for several years." | 2.44 | The importance of sodium/iodide symporter (NIS) for thyroid cancer management. ( Carvalho, DP; Ferreira, AC, 2007) |
| "Iodine is a trace element that is essential for the synthesis of thyroid hormone." | 2.44 | Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. ( Knobel, M; Medeiros-Neto, G, 2007) |
| "We examined thyroid cancer incidence patterns using data from the Sao Paulo Cancer Registry (SPCR) in Brazil and the National Cancer Institute's Surveillance Epidemiology End Results (SEER) program in the United States." | 1.39 | Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008. ( Aschebrook-Kilfoy, B; Devesa, SS; Neta, G; Ron, E; Veiga, LH, 2013) |
| "The incidence of thyroid cancer has increased within the last decade, an increase that is accounted for mostly by differentiated tumors." | 1.38 | Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009. ( Ceda, GP; Ceresini, G; Corcione, L; Gilli, A; Michiara, M; Sgargi, P; Silini, E; Teresi, G; Usberti, E, 2012) |
| "Iodine intake was measured in elementary schoolchildren in the Split-Dalmatia and Osijek-Baranya Counties." | 1.37 | Iodine intake and epidemiological characteristics of thyroid cancer: comparison between inland and littoral Croatia. ( Colović, Z; Jeroncić, I; Kontić, M; Luksić, B; Mulić, R; Poljak, NK, 2011) |
| "We studied all thyroid cancers notified to the Danish Cancer Registry in the period 1973-1997, focusing on the four most frequent subtypes: papillary, follicular, anaplastic and medullary thyroid cancer." | 1.33 | Iodine intake and incidence of thyroid cancer in Denmark. ( Johansen, C; Knudsen, N; Perrild, H; Sehestedt, T, 2006) |
| "Thyroid carcinoma was detected in 37 of the operated children, i." | 1.32 | A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster. ( Breborowicz, D; Breborowicz, J; Harasymczuk, J; Korman, E; Niedziela, M; Rolski, M; Trejster, E; Warzywoda, M, 2004) |
| "In 1990 rise in thyroid cancer IR was observed." | 1.31 | [Iodine deficiency and thyroid neoplasms in the Krakow region]. ( Buziak-Bereza, M; Gołkowski, F; Huszno, B; Pantofliński, J; Przybylik-Mazurek, E; Szybiński, Z; Trofimiuk, M, 2001) |
| "Mean incidence rates of papillary and follicular thyroid carcinoma were calculated for regions of Silesia by averaging the rates of the communities in each region." | 1.31 | [Geographic differences in iodine supply in the Silesia terrain in relation to thyroid cancer risk]. ( Bijak, A; Bogacz, A; Handkiewicz-Junak, D; Kochańska-Dziurowicz, A; Kurzeja, E; Stanjek, A; Szpak, S; Zeman, M; Zemła, B, 2001) |
| "Thirty-four cases of thyroid cancer were registered within 12 years after the accident." | 1.31 | [Correlation between endemic iodine deficiency and radiation-induced thyroid cancer in children and adolescents]. ( Marchenko, LF; Shakhtarin, VV; Stepanenko, VF; Tsyb, AF, 2002) |
| "The frequency of the anaplastic carcinoma during P1 (16." | 1.30 | The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. ( Bakiri, F; Djemli, FK; Djidel, FK; Mokrane, LA, 1998) |
| "We studied regional patterns of thyroid cancer incidence in relation to iodine intake and iodinization in Sweden using 5,838 incident cases diagnosed in the period 1958-1981." | 1.29 | Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. ( Adami, HO; Coleman, MP; Pettersson, B; Ron, E, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (14.58) | 18.2507 |
| 2000's | 28 (58.33) | 29.6817 |
| 2010's | 11 (22.92) | 24.3611 |
| 2020's | 2 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Maciel, J | 1 |
| Cavaco, D | 1 |
| Silvestre, C | 1 |
| Simões Pereira, J | 1 |
| Vilar, H | 1 |
| Leite, V | 1 |
| Barrea, L | 1 |
| Gallo, M | 1 |
| Ruggeri, RM | 1 |
| Giacinto, PD | 1 |
| Sesti, F | 1 |
| Prinzi, N | 1 |
| Adinolfi, V | 1 |
| Barucca, V | 1 |
| Renzelli, V | 1 |
| Muscogiuri, G | 1 |
| Colao, A | 1 |
| Baldelli, R | 1 |
| Veiga, LH | 1 |
| Neta, G | 1 |
| Aschebrook-Kilfoy, B | 1 |
| Ron, E | 2 |
| Devesa, SS | 1 |
| Proczko, M | 1 |
| Stefaniak, T | 1 |
| Sworczak, K | 1 |
| Kobiela, J | 1 |
| Lachiński, AJ | 1 |
| Stepaniak, P | 1 |
| Sledziński, Z | 1 |
| Shin, DY | 1 |
| Jo, YS | 2 |
| Kim, WG | 1 |
| Kim, TY | 1 |
| Kim, TH | 1 |
| Jang, HW | 1 |
| Park, YJ | 1 |
| Kim, SW | 1 |
| Kim, WB | 1 |
| Shong, M | 1 |
| Park, DJ | 1 |
| Chung, JH | 1 |
| Shong, YK | 1 |
| Cho, BY | 1 |
| Santos, JE | 2 |
| Kalk, WJ | 1 |
| Freitas, M | 2 |
| Marques Carreira, I | 1 |
| Castelo Branco, M | 1 |
| Fonseca, CP | 1 |
| Castilho, P | 1 |
| Carreira, IM | 1 |
| Rombeau, JL | 1 |
| Branco, MC | 1 |
| Harach, HR | 1 |
| Ceballos, GA | 1 |
| Filesi, M | 1 |
| Colandrea, M | 1 |
| Montesano, T | 1 |
| D'Apollo, R | 1 |
| Ronga, G | 2 |
| Sugitani, I | 1 |
| Toda, K | 1 |
| Yamamoto, N | 1 |
| Sakamoto, A | 1 |
| Fujimoto, Y | 1 |
| Taïeb, D | 1 |
| Sebag, F | 1 |
| Farman-Ara, B | 1 |
| Portal, T | 1 |
| Baumstarck-Barrau, K | 1 |
| Fortanier, C | 1 |
| Bourrelly, M | 1 |
| Mancini, J | 1 |
| De Micco, C | 1 |
| Auquier, P | 1 |
| Conte-Devolx, B | 1 |
| Henry, JF | 1 |
| Mundler, O | 1 |
| Poljak, NK | 1 |
| Kontić, M | 1 |
| Colović, Z | 1 |
| Jeroncić, I | 1 |
| Luksić, B | 1 |
| Mulić, R | 1 |
| Ceresini, G | 1 |
| Corcione, L | 1 |
| Michiara, M | 1 |
| Sgargi, P | 1 |
| Teresi, G | 1 |
| Gilli, A | 1 |
| Usberti, E | 1 |
| Silini, E | 1 |
| Ceda, GP | 1 |
| Kleiman, DA | 1 |
| Buitrago, D | 1 |
| Crowley, MJ | 1 |
| Beninato, T | 1 |
| Veach, AJ | 1 |
| Zanzonico, PB | 1 |
| Jin, M | 1 |
| Fahey, TJ | 1 |
| Zarnegar, R | 1 |
| Zemła, B | 2 |
| Huszno, B | 1 |
| Szybiński, Z | 1 |
| Trofimiuk, M | 1 |
| Przybylik-Mazurek, E | 1 |
| Buziak-Bereza, M | 1 |
| Gołkowski, F | 1 |
| Pantofliński, J | 1 |
| Szpak, S | 1 |
| Zeman, M | 1 |
| Handkiewicz-Junak, D | 1 |
| Kochańska-Dziurowicz, A | 1 |
| Kurzeja, E | 1 |
| Stanjek, A | 1 |
| Bijak, A | 1 |
| Bogacz, A | 1 |
| Klain, M | 1 |
| Ricard, M | 1 |
| Leboulleux, S | 1 |
| Baudin, E | 2 |
| Schlumberger, M | 3 |
| Shakhtarin, VV | 1 |
| Tsyb, AF | 1 |
| Stepanenko, VF | 1 |
| Marchenko, LF | 1 |
| Passler, C | 2 |
| Prager, G | 2 |
| Scheuba, C | 2 |
| Kaserer, K | 2 |
| Zettinig, G | 2 |
| Niederle, B | 2 |
| Son, HY | 1 |
| Nishikawa, A | 1 |
| Kanki, K | 1 |
| Okazaki, K | 1 |
| Kitamura, Y | 1 |
| Lee, KY | 1 |
| Umemura, T | 1 |
| Hirose, M | 1 |
| Niedziela, M | 1 |
| Korman, E | 1 |
| Breborowicz, D | 1 |
| Trejster, E | 1 |
| Harasymczuk, J | 1 |
| Warzywoda, M | 1 |
| Rolski, M | 1 |
| Breborowicz, J | 1 |
| Kaczirek, K | 1 |
| Gyory, F | 2 |
| Balazs, G | 2 |
| Nagy, EV | 2 |
| Juhasz, F | 2 |
| Mezosi, E | 2 |
| Szakall, S | 2 |
| Math, J | 2 |
| Lukacs, G | 2 |
| Bruno, R | 1 |
| Giannasio, P | 1 |
| Travagli, JP | 1 |
| Russo, D | 1 |
| Filetti, S | 2 |
| Sarda, AK | 1 |
| Kapur, MM | 1 |
| Gulcelik, MA | 1 |
| Gulcelik, NE | 1 |
| Dinc, S | 1 |
| Kuru, B | 1 |
| Camlibel, M | 1 |
| Alagol, H | 1 |
| Sehestedt, T | 1 |
| Knudsen, N | 1 |
| Perrild, H | 1 |
| Johansen, C | 1 |
| Mishra, A | 2 |
| Pal, L | 1 |
| Mishra, SK | 2 |
| Carvalho, DP | 1 |
| Ferreira, AC | 1 |
| Knobel, M | 1 |
| Medeiros-Neto, G | 1 |
| Kasagi, K | 1 |
| Fang, WT | 1 |
| Qao, BS | 1 |
| Wang, JB | 1 |
| Joseph, U | 1 |
| Schmidt, JA | 1 |
| Ehlenz, K | 1 |
| Leppek, R | 1 |
| Rothmund, M | 1 |
| von Wichert, P | 1 |
| Joseph, K | 1 |
| Pettersson, B | 1 |
| Coleman, MP | 1 |
| Adami, HO | 1 |
| Kanno, J | 1 |
| Ward, JM | 1 |
| Maronpot, RR | 1 |
| Lorberboym, M | 1 |
| Mechanick, JI | 1 |
| Bakiri, F | 1 |
| Djemli, FK | 1 |
| Mokrane, LA | 1 |
| Djidel, FK | 1 |
| Simon, D | 1 |
| Koehrle, J | 1 |
| Reiners, C | 1 |
| Boerner, AR | 1 |
| Schmutzler, C | 1 |
| Mainz, K | 1 |
| Goretzki, PE | 1 |
| Roeher, HD | 1 |
| Burgess, JR | 1 |
| Dwyer, T | 1 |
| McArdle, K | 1 |
| Tucker, P | 1 |
| Shugg, D | 1 |
| Schönberger, J | 1 |
| Bauer, J | 1 |
| Spruss, T | 1 |
| Weber, G | 1 |
| Chahoud, I | 1 |
| Eilles, C | 1 |
| Grimm, D | 1 |
| Duren, M | 1 |
| Yavuz, N | 1 |
| Bukey, Y | 1 |
| Ozyegin, MA | 1 |
| Gundogdu, S | 1 |
| Açbay, O | 1 |
| Hatemi, H | 1 |
| Uslu, I | 1 |
| Onsel, C | 1 |
| Aksoy, F | 1 |
| Oz, F | 1 |
| Unal, G | 1 |
| Duren, E | 1 |
| Bal, CS | 1 |
| Padhy, AK | 1 |
| Kumar, A | 1 |
| Mian, C | 1 |
| Lacroix, L | 1 |
| Bidart, JM | 1 |
| Caillou, B | 1 |
| Agarwal, A | 1 |
| Das, BK | 1 |
| Agarwal, G | 1 |
| Gambhir, S | 1 |
| Cappelli, C | 1 |
| Agosti, B | 1 |
| Tironi, A | 1 |
| Morassi, ML | 1 |
| Pelizzari, G | 1 |
| Cumetti, D | 1 |
| Cerudelli, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Distribution of Selenium in Patients With Differentiated Thyroid Carcinoma and Effect of Selenium Supplement on Prognosis of Patients With Differentiated Thyroid Carcinoma.[NCT04683575] | Phase 4 | 5,000 participants (Anticipated) | Interventional | 2022-05-30 | Not yet recruiting | ||
| Clinical Evaluation of a I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Using PROBE Design[NCT01704586] | 340 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | |||
| A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer[NCT03002623] | Phase 2 | 7 participants (Actual) | Interventional | 2016-12-22 | Terminated (stopped due to Study was closed because investigator left the National Institutes of Health.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Here is the count of participants with serious and non-serious adverse events assessed by the Common Terminology Criteria in Adverse Events (CTCAE v4.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT03002623)
Timeframe: Date treatment consent signed to date off study, approximately 12 months and 13 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Anaplastic Thyroid Cancer | 4 |
| Poorly Differentiated/Variants of Thyroid Cancer | 3 |
Time in days from the initiation of treatment until death estimated by the Kaplan-Meier method. (NCT03002623)
Timeframe: Approximately 12 months
| Intervention | Days (Median) |
|---|---|
| All Participants | 127 |
Time in days from initiation of treatment until tumor grows more than 20%. Progression was assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 and is at least a 20% increase in the sum of diameters of target lesions taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study) or the appearance of one or more new lesions. (NCT03002623)
Timeframe: Approximately 6 months
| Intervention | Days (Median) |
|---|---|
| Anaplastic Thyroid Cancer | 31.3 |
| Poorly Differentiated/Variants of Thyroid Cancer | 147 |
Clinical response, defined as a complete response + partial response (CR+PR) to CUDC-907 treatment, was assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1. Complete response is disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to <10 mm. Partial response is at least a 30% decrease in the sum of diameters of target lesions taking as reference the baseline sum diameters. (NCT03002623)
Timeframe: Approximately 6 months
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Complete Response | Partial Response | |
| Anaplastic Thyroid Cancer | 0 | 0 |
| Poorly Differentiated/Variants of Thyroid Cancer | 0 | 0 |
10 reviews available for iodine and Adenocarcinoma, Follicular
| Article | Year |
|---|---|
Nutritional status and follicular-derived thyroid cancer: An update.
Topics: Adenocarcinoma, Follicular; Animals; Iodine; Nutritional Status; Obesity; Thyroid Neoplasms | 2021 |
Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model.
Topics: Adenocarcinoma, Follicular; Adenoma; Argentina; Carcinoma, Papillary, Follicular; Diet; Female; Goit | 2008 |
Thyroid stunning in clinical practice: is it a real problem?
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Humans; Hyperthyroidism; Iodine; Iodine Radioisoto | 2009 |
Radioiodine therapy for papillary and follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Clinical Trials as Topic; Combined Modality | 2002 |
The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
Topics: Adenocarcinoma, Follicular; Biological Transport; Carcinoma, Papillary; Cloning, Molecular; Down-Reg | 2007 |
Relevance of iodine intake as a reputed predisposing factor for thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Animals; Argentina; Diet; Disease Models, Ani | 2007 |
[Epidemiology of thyroid tumors: effect of environmental iodine intake].
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Age Factors; Female; Graves Disease; Humans; | 2007 |
[Iodine-induced hyperthyroidism in metastatic thyroid carcinoma].
Topics: Adenocarcinoma, Follicular; Aged; Bone Neoplasms; Diagnosis, Differential; Fatal Outcome; Humans; Hy | 1994 |
Mechanisms of chemically induced thyroid follicular carcinogenesis.
Topics: Adenocarcinoma, Follicular; Animals; Carcinogens; Humans; Iodine; Mutagens; Thyroid Gland; Thyroid H | 1996 |
Sodium/iodide symporter in thyroid cancer.
Topics: Adenocarcinoma, Follicular; Age Factors; Animals; Biological Transport; Carcinoma, Papillary; Clonin | 2001 |
2 trials available for iodine and Adenocarcinoma, Follicular
| Article | Year |
|---|---|
Completion thyroidectomy of well-differentiated thyroid cancer - a prospective, randomised study.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Humans; Iodine; Iodine Radioisotopes; Lymph Node E | 2013 |
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.
Topics: Ablation Techniques; Adenocarcinoma, Follicular; Carcinoma, Papillary; Combined Modality Therapy; Ha | 2010 |
36 other studies available for iodine and Adenocarcinoma, Follicular
| Article | Year |
|---|---|
Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Hepatocellular; Female; Humans; Iodine; Iodine Radioisotopes; | 2022 |
Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Topics: Adenocarcinoma, Follicular; Age Factors; Brazil; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Pa | 2013 |
Clinical implications of follicular and Hurthle cell carcinoma in an iodine-sufficient area.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Diet; Female; Humans; Iodine; Male; Nutritional Stat | 2014 |
Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adult; Age Factors; Diet; Female; Humans; Iodine; Ly | 2014 |
Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Medullary; Carcinoma, Neu | 2015 |
Iodine deficiency a persisting problem: assessment of iodine nutrition and evaluation of thyroid nodular pathology in Portugal.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papill | 2017 |
Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Chi-Sq | 2010 |
Iodine intake and epidemiological characteristics of thyroid cancer: comparison between inland and littoral Croatia.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Carcinoma, Papillary; Child; Child, Preschool; Croati | 2011 |
Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.
Topics: Adenocarcinoma, Follicular; Carcinoma; Carcinoma, Papillary; Female; Humans; Incidence; Iodine; Ital | 2012 |
Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing.
Topics: Adenocarcinoma, Follicular; Cell Line, Tumor; Gene Silencing; Humans; In Vitro Techniques; Iodine; I | 2013 |
[Occurrence of papillary and follicular thyroid cancer among Silesian women].
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Endemic Diseases; Female; Humans; Incidence | 2001 |
[Iodine deficiency and thyroid neoplasms in the Krakow region].
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Child; Comorbidity; Deficiency Diseas | 2001 |
[Geographic differences in iodine supply in the Silesia terrain in relation to thyroid cancer risk].
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Child; Deficiency Diseases; Endemic Diseases; Envi | 2001 |
[Correlation between endemic iodine deficiency and radiation-induced thyroid cancer in children and adolescents].
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Age Factors; Carcinoma, Papillary; Child; Child, Pres | 2002 |
Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adolescent; Adult; Aged; Aged, 80 and over; C | 2003 |
Synergistic interaction between excess caffeine and deficient iodine on the promotion of thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine.
Topics: Adenocarcinoma, Follicular; Adenoma; Animals; Anti-Infective Agents, Local; Caffeine; Carcinogens; C | 2003 |
A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Carcinoma, Medullary; Carcinoma, Papillary; Child; Fe | 2004 |
Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Carcinoma, Papillary; Child; Female; Goiter, En | 2004 |
Differentiated thyroid cancer and outcome in iodine deficiency.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Deficiency Diseases; Female; Humans; H | 2004 |
Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Child; | 2004 |
Thyroid surgery in an area of iodine deficiency.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Catchment Area, Health; Female; Follow | 2005 |
The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Female; Goiter, Nodular; Humans; Hyperthyro | 2006 |
Iodine intake and incidence of thyroid cancer in Denmark.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Carcinoma; Carcinoma, Medullary; | 2006 |
Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Carcino | 2007 |
[Iodine deficiency induces thyroid cancer in rats and mice].
Topics: Adenocarcinoma, Follicular; Animals; Carcinoma, Papillary; Deficiency Diseases; Female; Hyperplasia; | 1994 |
Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Age Factors; Aged; Carcinoma, Papillary; Child; Femal | 1996 |
Accelerated thyrotoxicosis induced by iodinated contrast media in metastatic differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Choristoma; Contrast Media; Female; Humans; Iodine; Iodine Radiois | 1996 |
The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Algeria; Carcinoma; Developing Countries; Female; Goiter; Humans; | 1998 |
Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Humans; Iodine; Male; Middle | 1998 |
The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Endemic Diseases; Female; Humans; Iod | 2000 |
Establishment and characterization of the follicular thyroid carcinoma cell line ML-1.
Topics: Adenocarcinoma, Follicular; Animals; Cell Transplantation; Deoxyglucose; DNA, Neoplasm; Female; Flow | 2000 |
Impact of initial surgical treatment on survival of patients with differentiated thyroid cancer: experience of an endocrine surgery center in an iodine-deficient region.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Deficiency Diseases; Endemic | 2000 |
[Differentiated thyroid carcinoma: prognostic factors].
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Deficiency Diseases; Femal | 2001 |
Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Age Distribution; Bone Neoplasms; Carcinoma, Papillar | 2001 |
Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Combined Modality The | 2002 |
[Prevalence and aggressiveness of thyroid carcinoma with diameter less than one centimetre in iodine deficiency areas].
Topics: Adenocarcinoma, Follicular; Biopsy, Needle; Calcinosis; Carcinoma, Medullary; Carcinoma, Papillary; | 2002 |